• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于乳腺癌靶向治疗的双响应介孔二氧化硅纳米颗粒的设计与表征

Design and characterization of dual responsive mesoporous silica nanoparticles for breast cancer targeted therapy.

作者信息

Bhavsar Dhaval B, Patel Vijay, Sawant Krutika K

机构信息

Pharmacy Department, G. H. Patel Pharmacy Building, The M. S. University of Baroda, Fatehgunj, Vadodara 390002, Gujarat, India.

Animal Disease Investigation Unit, Alembic Road, Opp. Model Farm, Vadodara, 390 003, Gujarat, India.

出版信息

Eur J Pharm Sci. 2020 Sep 1;152:105428. doi: 10.1016/j.ejps.2020.105428. Epub 2020 Jun 15.

DOI:10.1016/j.ejps.2020.105428
PMID:32553643
Abstract

The main reason for limited efficacy of anticancer drug is the poor accretion of administered amount of drug within the tumor. Here, chitosan folate capped dual responsive mesoporous silica nanoparticles (MSNs) which can actively target cancer cells, and provide burst release of loaded anticancer drug within tumor cells and ultimately leading to improved therapeutic efficacy were synthesized. MSNs were synthesized using most economic silica source, sodium silicate. Doxorubicin (DOX) was loaded within the pores of MSNs and these drug loaded MSNs were first reacted with cystamine dihydrochloride followed by capping with chitosan-folate conjugate (CH-FA) to produce dual (redox and pH) responsive nanoparticles with the ability to actively target breast cancer cells. A triggered release of DOX from MSNs under acidic redox (pH 5.5, 10 mM GSH) environment was confirmed by in vitro release studies. The formulation exhibited 2.14 and 1.65 folds higher cytotoxicity than free drug against MCF-7 and MDA-MB-231 cells. DOX-MSN-SS-CH-FA showed superior tumor suppressing activity as compared to DOX-MSN or DOX alone in the treatment of Ehrlich Ascites Carcinoma (EAC) induced breast cancer with significantly reduced hematological and organ specific toxicities associated with DOX treatment.

摘要

抗癌药物疗效有限的主要原因是肿瘤内给药量的累积不佳。在此,合成了壳聚糖叶酸包覆的双响应介孔二氧化硅纳米颗粒(MSNs),其可主动靶向癌细胞,并在肿瘤细胞内实现负载抗癌药物的突发释放,最终提高治疗效果。MSNs使用最经济的硅源硅酸钠合成。阿霉素(DOX)负载于MSNs的孔内,这些载药MSNs首先与二盐酸半胱胺反应,然后用壳聚糖 - 叶酸共轭物(CH - FA)包覆,以制备具有主动靶向乳腺癌细胞能力的双(氧化还原和pH)响应纳米颗粒。体外释放研究证实了在酸性氧化还原(pH 5.5,10 mM GSH)环境下DOX从MSNs的触发释放。该制剂对MCF - 7和MDA - MB - 231细胞的细胞毒性比游离药物分别高2.14倍和1.65倍。在治疗艾氏腹水癌(EAC)诱导的乳腺癌中,DOX - MSN - SS - CH - FA与DOX - MSN或单独的DOX相比显示出优异的肿瘤抑制活性,且与DOX治疗相关的血液学和器官特异性毒性显著降低。

相似文献

1
Design and characterization of dual responsive mesoporous silica nanoparticles for breast cancer targeted therapy.用于乳腺癌靶向治疗的双响应介孔二氧化硅纳米颗粒的设计与表征
Eur J Pharm Sci. 2020 Sep 1;152:105428. doi: 10.1016/j.ejps.2020.105428. Epub 2020 Jun 15.
2
A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.一种双功能 HER2 适体偶联、pH 激活的介孔硅纳米载体药物传递系统,为 HER2 阳性乳腺癌细胞提供体外协同细胞毒性。
Int J Nanomedicine. 2019 May 31;14:4029-4044. doi: 10.2147/IJN.S201688. eCollection 2019.
3
Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release.用于pH响应性阿霉素释放的聚天冬氨酸锚定介孔二氧化硅纳米粒子
Int J Nanomedicine. 2018 Feb 19;13:1029-1040. doi: 10.2147/IJN.S146955. eCollection 2018.
4
Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer.载多柔比星和针对转移性乳腺癌的 siRNA 的靶向肿瘤和氧化还原响应介孔硅纳米粒子的控释。
Int J Nanomedicine. 2021 Mar 8;16:1961-1976. doi: 10.2147/IJN.S278724. eCollection 2021.
5
Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.用于氧化还原/酶双响应靶向和可控药物递送及实时生物成像的荧光碳点门控多功能介孔二氧化硅纳米载体
Eur J Pharm Biopharm. 2017 Aug;117:105-115. doi: 10.1016/j.ejpb.2017.03.019. Epub 2017 Mar 28.
6
TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.TPGS 功能化介孔硅纳米粒子用于抗癌药物传递以克服多药耐药性。
Mater Sci Eng C Mater Biol Appl. 2018 Mar 1;84:108-117. doi: 10.1016/j.msec.2017.11.040. Epub 2017 Nov 28.
7
Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles.智能 ATP 响应 Y 型 DNA 结构封端的介孔硅纳米粒子对癌细胞的靶向递送和控制释放阿霉素。
J Mater Chem B. 2021 Feb 15;9(5):1351-1363. doi: 10.1039/d0tb01960g.
8
Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.用可被肿瘤脱落的透明质酸修饰的多功能介孔二氧化硅纳米颗粒作为阿霉素的载体
Colloids Surf B Biointerfaces. 2016 Aug 1;144:293-302. doi: 10.1016/j.colsurfb.2016.04.015. Epub 2016 Apr 8.
9
Multifunctional Peptide-Amphiphile End-Capped Mesoporous Silica Nanoparticles for Tumor Targeting Drug Delivery.多功能肽两亲嵌段介孔硅纳米粒子用于肿瘤靶向药物递送。
ACS Appl Mater Interfaces. 2017 Jan 25;9(3):2093-2103. doi: 10.1021/acsami.6b12647. Epub 2017 Jan 12.
10
Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.壳聚糖包覆的介孔二氧化硅纳米粒子作为用于药物控释的pH响应性纳米载体。
Chem Asian J. 2014 Jan;9(1):319-27. doi: 10.1002/asia.201301105. Epub 2013 Oct 2.

引用本文的文献

1
Organocyclophosphazenes and Materials Based on Them for Pharmaceuticals and Biomedicine.用于制药和生物医学的有机环磷腈及其基材料。
Biomolecules. 2025 Feb 11;15(2):262. doi: 10.3390/biom15020262.
2
Pioneering Advances and Innovative Applications of Mesoporous Carriers for Mitochondria-Targeted Therapeutics.介孔载体用于线粒体靶向治疗的开创性进展与创新应用
Br J Biomed Sci. 2024 Nov 18;81:13707. doi: 10.3389/bjbs.2024.13707. eCollection 2024.
3
Optimized DOX Drug Deliveries via Chitosan-Mediated Nanoparticles and Stimuli Responses in Cancer Chemotherapy: A Review.
壳聚糖介导的纳米粒子优化 DOX 药物传递及癌症化疗中的刺激响应:综述。
Molecules. 2023 Dec 20;29(1):31. doi: 10.3390/molecules29010031.
4
Unveiling innovative therapeutic strategies and future trajectories on stimuli-responsive drug delivery systems for targeted treatment of breast carcinoma.揭示用于乳腺癌靶向治疗的刺激响应性药物递送系统的创新治疗策略和未来发展轨迹。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun;397(6):3747-3770. doi: 10.1007/s00210-023-02885-9. Epub 2023 Dec 14.
5
Nano-engineering nanomedicines with customized functions for tumor treatment applications.纳米工程纳米药物,赋予其针对肿瘤治疗应用的定制功能。
J Nanobiotechnology. 2023 Aug 2;21(1):250. doi: 10.1186/s12951-023-01975-3.
6
Glutathione Programmed Mitochondria Targeted Delivery of Lonidamine for Effective Against Triple Negative Breast Cancer.基于谷胱甘肽的线粒体靶向载药传递系统用于递送洛尼达明治疗三阴性乳腺癌的研究
Int J Nanomedicine. 2023 Jul 24;18:4023-4042. doi: 10.2147/IJN.S413217. eCollection 2023.
7
Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting.阿霉素制剂在增强药代动力学和肿瘤靶向性方面的最新进展
Pharmaceuticals (Basel). 2023 May 29;16(6):802. doi: 10.3390/ph16060802.
8
Multi-Layered PLGA-PEI Nanoparticles Functionalized with TKD Peptide for Targeted Delivery of Pep5 to Breast Tumor Cells and Spheroids.TKD 肽功能化的多层 PLGA-PEI 纳米颗粒用于 Pep5 靶向递送至乳腺癌肿瘤细胞和球体。
Int J Nanomedicine. 2022 Nov 22;17:5581-5600. doi: 10.2147/IJN.S376358. eCollection 2022.
9
2D Hetero-Nanoconstructs of Black Phosphorus for Breast Cancer Theragnosis: Technological Advancements.二维黑磷杂化纳米结构用于乳腺癌诊疗一体化:技术进展
Biosensors (Basel). 2022 Nov 11;12(11):1009. doi: 10.3390/bios12111009.
10
Application of Mesoporous Silica Nanoparticles in Cancer Therapy and Delivery of Repurposed Anthelmintics for Cancer Therapy.介孔二氧化硅纳米颗粒在癌症治疗中的应用以及重新利用抗蠕虫药用于癌症治疗的递送
Pharmaceutics. 2022 Jul 29;14(8):1579. doi: 10.3390/pharmaceutics14081579.